ALPL and hypophosphatasia: In Akp2Hpp/+ mice, an Alpl loss-of-function mutation led to the rare disease hypophosphatasia (HPP) which displays reduction of plasma ALP activities to about 50 % in Akp2Hpp/+ and a stronger reduction in Akp2Hpp/Hpp mice.